Detalhe da pesquisa
1.
Process development for production and purification of the Schistosoma mansoni Sm14 antigen.
Protein Expr Purif
; 134: 72-81, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389350
2.
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1.
Cancer Immunol Immunother
; 64(3): 311-23, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403749
3.
PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.
Eur J Nucl Med Mol Imaging
; 42(11): 1700-1706, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194713
4.
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.
Proc Natl Acad Sci U S A
; 109(15): 5797-802, 2012 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454499
5.
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
Int J Cancer
; 135(5): 1142-52, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24482145
6.
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.
Eur J Immunol
; 43(4): 989-1000, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23436617
7.
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
J Immunol
; 188(8): 3851-8, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22427632
8.
Trypanosoma cruzi as an effective cancer antigen delivery vector.
Proc Natl Acad Sci U S A
; 108(49): 19695-700, 2011 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22114198
9.
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
Proc Natl Acad Sci U S A
; 108(40): 16723-8, 2011 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933959
10.
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy.
J Exp Med
; 204(4): 831-40, 2007 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-17389240
11.
Imaging of tumor vascularization using fluorescence molecular tomography to monitor arginine deiminase treatment in melanoma.
Mol Imaging
; 12(1): 67-73, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23348793
12.
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.
Cancer Immun
; 13: 3, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23390374
13.
NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.
Cancer Immun
; 13: 12, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23882157
14.
Process development and production of cGMP grade Melan-A for cancer vaccine clinical trials.
Protein Expr Purif
; 92(2): 171-82, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24045055
15.
Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
J Immunol
; 186(2): 1218-27, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21149605
16.
Seromic profiling of ovarian and pancreatic cancer.
Proc Natl Acad Sci U S A
; 107(11): 5088-93, 2010 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20194765
17.
Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.
Int J Cancer
; 130(7): 1598-606, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21547902
18.
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
Int J Cancer
; 130(3): 584-92, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21413013
19.
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.
Proc Natl Acad Sci U S A
; 106(13): 5082-7, 2009 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289842
20.
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
J Immunol
; 183(7): 4800-8, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734225